KINOYAMA ISAO

Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…

Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…

Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…

Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…

Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…

Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…

Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…

Disclosed are 1,3-dihydro-2H-benzimidazol-2-ylidene derivatives as represented by the general formula (I) which are gonadotrophin releasing hormone (GnRH) receptor antagonists wherein A is optionally substituted aryl or optionally substitut…

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …

Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is optionally substituted benzene, optionally substituted pyridine, or thiophene, B is benzene or thiophene, R1 is H or -CO-lower alkyl, or R1 …

Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is optionally substituted benzene, optionally substituted pyridine, or thiophene, B is benzene or thiophene, R1 is H or -CO-lower alkyl, or R1 …

Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is optionally substituted benzene, optionally substituted pyridine, or thiophene, B is benzene or thiophene, R1 is H or -CO-lower alkyl, or R1 …

Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is optionally substituted benzene, optionally substituted pyridine, or thiophene, B is benzene or thiophene, R1 is H or -CO-lower alkyl, or R1 …

Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is optionally substituted benzene, optionally substituted pyridine, or thiophene, B is benzene or thiophene, R1 is H or -CO-lower alkyl, or R1 …

Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is optionally substituted benzene, optionally substituted pyridine, or thiophene, B is benzene or thiophene, R1 is H or -CO-lower alkyl, or R1 …

Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is optionally substituted benzene, optionally substituted pyridine, or thiophene, B is benzene or thiophene, R1 is H or -CO-lower alkyl, or R1 …

Disclosed is a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein A is optionally substituted benzene, optionally substituted pyridine, or thiophene, B is benzene or thiophene, R1 is H or -CO-lower alkyl, or R1 …

Compounds useful as GnRH receptor antagonists are provided. The present inventors have further examined propane-1,3-dione derivatives and confirmed as a result that a propane-1,3-dione having 2-(1,3-dihydro-2H-benzimidazol-2-ylidene), or a …